Devlin Jodi — SEC Form 4 filings

SEC reporting owner CIK 1992151. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-20.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-02-14 to 2026-03-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
TriSalus Life Sciences, Inc. (TLSI)Chief of Clinical Operations64 legs · 7,971 sh · $37,8498

Form 4 filings — Devlin Jodi

FiledFormIssuerReported transactionsSource
2026-03-204TriSalus Life Sciences, Inc. (TLSI)Sale (S): 1,162 @ $4.13 · Sale (S): 1,772 @ $4.09 · Sale (S): 273 @ $4.12EDGAR
2025-11-254TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 50,000 @ $0 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-05-214TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 24,131 @ $5.18 · Sale (S): 4,764 @ $5.18EDGAR
2025-02-194TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 5,272 @ $0EDGAR
2025-01-294TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 10,625 @ $0 · Grant/award (A): 63,750 (derivative) @ $0EDGAR
2024-02-144TriSalus Life Sciences, Inc. (TLSI)Grant/award (A): 17,500 @ $0 · Grant/award (A): 105,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1992151 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →